Arkema (OTCMKTS:ARKAY – Get Free Report) and Albemarle (NYSE:ALB – Get Free Report) are both basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership.
Insider & Institutional Ownership
92.9% of Albemarle shares are held by institutional investors. 0.4% of Albemarle shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Dividends
Arkema pays an annual dividend of $3.12 per share and has a dividend yield of 4.8%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. Arkema pays out 1,248.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Albemarle pays out -47.5% of its earnings in the form of a dividend. Albemarle has increased its dividend for 30 consecutive years.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Arkema | $10.26 billion | 0.48 | $71.28 million | $0.25 | 259.12 |
| Albemarle | $5.14 billion | 3.10 | -$510.63 million | ($3.41) | -39.67 |
Arkema has higher revenue and earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Arkema, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and target prices for Arkema and Albemarle, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Arkema | 2 | 5 | 1 | 0 | 1.88 |
| Albemarle | 1 | 10 | 15 | 1 | 2.59 |
Albemarle has a consensus target price of $199.58, indicating a potential upside of 47.55%. Given Albemarle’s stronger consensus rating and higher possible upside, analysts plainly believe Albemarle is more favorable than Arkema.
Profitability
This table compares Arkema and Albemarle’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Arkema | 0.46% | 4.06% | 2.08% |
| Albemarle | -5.00% | 5.22% | 2.51% |
Volatility & Risk
Arkema has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500.
Summary
Albemarle beats Arkema on 12 of the 18 factors compared between the two stocks.
About Arkema
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. This segment also offers performance polymers, such as specialty polyamides, PVDF, polyimides, fluorospecialties, and polyetherketoneketone; and performance additives which includes molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide. The Advance Materials and Coating Solutions segment offers coating solutions, including comprising EU/US acrylics and coating resins; coating additives, such as sartomer photocure resins and coatex rheology additives. This segment also provides decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbent, water treatment and oil and gas extraction, and 3D printing and electronics industries. The Intermediates segment provides fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
